Fig. A.2.

Effects of the proportion of symptomatic infections $p_i$ and the infectious period $1∕\gamma$ on the efficacy ${\mathcal{F}}_i$ with fixed $T_1=30$ days and $s_2^{\left(1\right)}=0.4$. All other parameters are the same as in Fig. 5, Fig. 6.